Speakers | Kisaco Research

Check back for updates - expect 120+ speakers from across the Animal Health Landscape. 

STAY IN THE LOOP

  • Author:

    Paul Horwood

    UK Head of Farm
    IVC Evidensia

    Paul Horwood

    UK Head of Farm
    IVC Evidensia
  • Author:

    Gudrun Ravetz

    Group Chief Medical Officer
    IVC Evidensia

    Currently Gudrun works as a Veterinary Consultant to Pet Health Plans from Denplan and as an external interviewer for prospective veterinary students at University of Liverpool. Alongside practicing as a small animal veterinary surgeon on graduating in 2002, Gudrun furthered her interest in the business side of the veterinary profession by studying for the post graduate certificate in business. Gudrun became President at the BVA Member’s Day and AGM on 22 September 2016.

    Gudrun Ravetz

    Group Chief Medical Officer
    IVC Evidensia

    Currently Gudrun works as a Veterinary Consultant to Pet Health Plans from Denplan and as an external interviewer for prospective veterinary students at University of Liverpool. Alongside practicing as a small animal veterinary surgeon on graduating in 2002, Gudrun furthered her interest in the business side of the veterinary profession by studying for the post graduate certificate in business. Gudrun became President at the BVA Member’s Day and AGM on 22 September 2016.

  • Author:

    Oliver Viner

    Co-Founder & Chief Veterinary Technology Officer
    Hello Vet

    Oliver Viner

    Co-Founder & Chief Veterinary Technology Officer
    Hello Vet
  • Author:

    Ben Johnson BVetMed MRCVS

    Founding Director
    Pet Practice Partners

    Ben Johnson BVetMed MRCVS

    Founding Director
    Pet Practice Partners
  • Author:

    Paul Dick

    President
    Paul Dick & Associates

    Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

    While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

    His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

    Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

    In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

    Paul Dick

    President
    Paul Dick & Associates

    Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

    While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

    His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

    Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

    In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

  • Author:

    Charlotte Jennings

    Chief Veterinary & Partnership Officer
    Medivet

    Charlotte Jennings

    Chief Veterinary & Partnership Officer
    Medivet
  • Author:

    Adele Williams

    AI & Clinical Data Consultant
    AWX Consultancy

    Adele Williams

    AI & Clinical Data Consultant
    AWX Consultancy
  • Author:

    Linda Black

    CEO
    Gallant Therapeutics

    Linda Black

    CEO
    Gallant Therapeutics
  • Author:

    Julie Lawless

    President
    Lawless Strategic Communications

    Julie Lawless

    President
    Lawless Strategic Communications
  • Author:

    Rob Kelly

    SVP, Global Marketing & Commercial Leader EURAM
    MSD Animal Health

    Rob Kelly

    SVP, Global Marketing & Commercial Leader EURAM
    MSD Animal Health
  • Author:

    Matthias Hofer

    Managing Partner
    Stonehaven Cozmix Group

    Matthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.

    Matthias Hofer

    Managing Partner
    Stonehaven Cozmix Group

    Matthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.

  • Author:

    Chad Terrell

    Head of Business Development
    Stonehaven Cozmix Group

    Chad Terrell

    Head of Business Development
    Stonehaven Cozmix Group
  • Author:

    Dr. Kimberly Simmons

    Director Global Regulatory Affairs
    Clinglobal

    Dr. Kimberly Simmons

    Director Global Regulatory Affairs
    Clinglobal
  • Author:

    Karin Jager

    Senior Vice President, Strategic Client Partnerships
    Circa Healthcare

    Karin Jager

    Senior Vice President, Strategic Client Partnerships
    Circa Healthcare
  • Author:

    Tim Bettington

    Executive Vice President, Corporate Strategy & Market Development
    Elanco

    Tim Bettington

    Executive Vice President, Corporate Strategy & Market Development
    Elanco
  • Author:

    Aaron Schact

    CEO
    Biomedit

    Aaron Schact

    CEO
    Biomedit
  • Author:

    Oli Viner

    Owner
    Hello Vet

    Oli Viner

    Owner
    Hello Vet
  • Author:

    Rebecca Windsor

    Director of Veterinary Affairs
    Gallant

    Rebecca Windsor

    Director of Veterinary Affairs
    Gallant
  • Author:

    Jake Burlet

    CEO
    CanBiocin

    Jake Burlet

    CEO
    CanBiocin